Role of corticotrophin-releasing factor in effects of leptin on sympathetic nerve activity and arterial pressure.
- 1 September 2001
- journal article
- other
- Published by Wolters Kluwer Health in Hypertension
- Vol. 38 (3) , 384-388
- https://doi.org/10.1161/01.hyp.38.3.384
Abstract
Leptin and corticotrophin-releasing factor increase sympathetic nervous activity to interscapular brown adipose tissue, kidneys, and adrenal glands. Leptin is known to increase hypothalamic corticotrophin-releasing factor. In this study, we tested the hypothesis that leptin-dependent increases in sympathetic nervous activity are mediated through increases in central nervous system corticotrophin-releasing factor activity. We examined the effects of intracerebroventricular administration of corticotrophin-releasing factor and intravenous leptin on sympathetic nervous activity to interscapular brown adipose tissue through multifiber neurography in anesthetized Sprague-Dawley rats pretreated with intracerebroventricular α-helical corticotrophin-releasing factor 9–41 (corticotrophin-releasing factor receptor antagonist) or vehicle. Centrally administered corticotrophin-releasing factor substantially increased interscapular brown adipose tissue sympathetic nervous activity. The responses to corticotrophin-releasing factor were substantially attenuated in animals pretreated with α-helical corticotrophin-releasing factor 9–41 . Leptin-dependent increases in interscapular brown adipose tissue sympathetic nervous activity were significantly inhibited by pretreatment with α-helical corticotrophin-releasing factor 9–41 . Interestingly, leptin also significantly increased arterial pressure over 6 hours, but this pressor action was not attenuated by the corticotrophin-releasing factor receptor antagonist. These results suggest that corticotrophin-releasing factor may mediate the sympathoexcitatory effect of leptin on thermogenic tissue without altering its cardiovascular actions.Keywords
This publication has 22 references indexed in Scilit:
- Contrasting blood pressure effects of obesity in leptin-deficient ob/ob mice and agouti yellow obese miceJournal Of Hypertension, 1999
- Human Leptin Deficiency Caused by a Missense Mutation: Multiple Endocrine Defects, Decreased Sympathetic Tone, and Immune System Dysfunction Indicate New Targets for Leptin Action, Greater Central than Peripheral Resistance to the Effects of Leptin, and Spontaneous Correction of Leptin-Mediated DefectsJournal of Clinical Endocrinology & Metabolism, 1999
- Hypothalamic corticotropin-releasing hormone is a mediator of the anorexigenic effect of leptin.Diabetes, 1998
- Hypothalamic Pro-Opiomelanocortin mRNA Is Reduced By Fasting in ob/ob and db/db Mice, but Is Stimulated by LeptinDiabetes, 1998
- Receptor-mediated regional sympathetic nerve activation by leptin.Journal of Clinical Investigation, 1997
- Specificity of Leptin Action on Elevated Blood Glucose Levels and Hypothalamic Neuropeptide Y Gene Expression in ob/ob MiceDiabetes, 1996
- The role of neuropeptide Y in the antiobesity action of the obese gene productNature, 1995
- Recombinant Mouse OB Protein: Evidence for a Peripheral Signal Linking Adiposity and Central Neural NetworksScience, 1995
- Effects of the obese Gene Product on Body Weight Regulation in ob / ob MiceScience, 1995
- Effect of corticotropin releasing hormone and neuropeptide Y on electrophysiological activity of sympathetic nerves to interscapular brown adipose tissueNeuroscience, 1990